Literature DB >> 7535614

Immunoglobulin fold characteristics of B7-1 (CD80) and B7-2 (CD86).

J Bajorath1, R J Peach, P S Linsley.   

Abstract

B7-1 and B7-2 are expressed on antigen-presenting cells and bind to the CD28 and CTLA-4 receptors on T cells. These interactions trigger a costimulatory pathway that is essential for T-cell activation. B7-1 and B7-2 are members of the immunoglobulin superfamily (IgSF) and, despite sharing common function, have only limited sequence similarity. The B7-1 extracellular region was previously subdivided into 2 IgSF domains, an N-terminal V(ariable)-like domain, followed by a C(onstant)-like domain. We recently reported that the V-like domains of B7-1 and B7-2 share some significant sequence similarities with 3 major histocompatibility complex (MHC)-encoded members of the IgSF. We have now applied inverse folding methodology to assess the compatibility of the B7-1 and B7-2 extracellular region sequences with currently available 3-dimensional structures. In these calculations, the sequences of the N-terminal (V-like) domains in B7-1 and B7-2 were not compatible with known structures, including the IgSF V-set. In contrast, the sequences of the C-like domains were compatible with IgSF C-set structures and were best recognized by the beta 2-microglobulin (beta 2m) domain of MHC Class I. A sequence comparison of the C-like domains in the B7 molecules showed that 11 of 17 rigorously conserved residues in B7-1 and B7-2 are not IgSF C-1 set consensus residues. When mapped onto the corresponding positions of the beta 2m structure, the conserved residues in B7 cluster on the surface, where they may interact with the B7 V-like domain or other molecules.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535614      PMCID: PMC2142637          DOI: 10.1002/pro.5560031128

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  9 in total

1.  Topology fingerprint approach to the inverse protein folding problem.

Authors:  A Godzik; A Kolinski; J Skolnick
Journal:  J Mol Biol       Date:  1992-09-05       Impact factor: 5.469

2.  Specificity pockets for the side chains of peptide antigens in HLA-Aw68.

Authors:  T P Garrett; M A Saper; P J Bjorkman; J L Strominger; D C Wiley
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

3.  B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells.

Authors:  G J Freeman; A S Freedman; J M Segil; G Lee; J F Whitman; L M Nadler
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

Review 4.  De novo and inverse folding predictions of protein structure and dynamics.

Authors:  A Godzik; A Kolinski; J Skolnick
Journal:  J Comput Aided Mol Des       Date:  1993-08       Impact factor: 3.686

Review 5.  The role of the CD28 receptor during T cell responses to antigen.

Authors:  P S Linsley; J A Ledbetter
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

6.  Recognition of errors in three-dimensional structures of proteins.

Authors:  M J Sippl
Journal:  Proteins       Date:  1993-12

7.  Cloning and analysis of cDNA encoding bovine butyrophilin, an apical glycoprotein expressed in mammary tissue and secreted in association with the milk-fat globule membrane during lactation.

Authors:  L J Jack; I H Mather
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

8.  Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.

Authors:  G J Freeman; J G Gribben; V A Boussiotis; J W Ng; V A Restivo; L A Lombard; G S Gray; L M Nadler
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

9.  X-ray structure determination of telokin, the C-terminal domain of myosin light chain kinase, at 2.8 A resolution.

Authors:  H M Holden; M Ito; D J Hartshorne; I Rayment
Journal:  J Mol Biol       Date:  1992-10-05       Impact factor: 5.469

  9 in total
  5 in total

Review 1.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

Review 2.  T cell costimulation, checkpoint inhibitors and anti-tumor therapy.

Authors:  Dipankar Nandi; Sanmoy Pathak; Taru Verma; Madhulika Singh; Avik Chattopadhyay; Samriddhi Thakur; Abinaya Raghavan; Abhijeet Gokhroo
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

3.  Expression of butyrophilin (Btn1a1) in lactating mammary gland is essential for the regulated secretion of milk-lipid droplets.

Authors:  Sherry L Ogg; Anne K Weldon; Lorraine Dobbie; Andrew J H Smith; Ian H Mather
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

4.  Cross-linking of CD80 and CD86 Diminishes Expression of CD54 on EBV-transformed B Cells through Inactivation of RhoA and Ras.

Authors:  Ga Bin Park; Yeong Seok Kim; Hyunkeun Song; Seonghan Kim; Dong Man Park; Wang Jae Lee; Dae Young Hur
Journal:  Immune Netw       Date:  2011-12-31       Impact factor: 6.303

5.  Treatment of a Woman With Glycyrrhiza glabra for Acute Sinusitis: A Case Report.

Authors:  Brett R Martin; Gaurav Reshamwala; Melanie Short
Journal:  J Chiropr Med       Date:  2019-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.